Impact of aging on treatment considerations for multiple sclerosis patients
With a rapidly aging global population and improvement of outcomes with newer multiple sclerosis (MS)-specific disease-modifying therapies (DMTs), the epidemiology of MS has shifted to an older than previously described population, with a peak prevalence of the disease seen in the 55–65 years age gr...
Bewaard in:
| Hoofdauteurs: | , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Frontiers Media S.A.
2023-07-01
|
| Reeks: | Frontiers in Neurology |
| Onderwerpen: | |
| Online toegang: | https://www.frontiersin.org/articles/10.3389/fneur.2023.1197212/full |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|